Nuclear Verdicts and the Death of the $1M Limit
Westfield Specialty Insights
A $10 million jury award used to be a story. In 2026, in several U.S. venues, it is a baseline. The combined pressure of social inflation, third-party litigation funding, and reptile-theory trial tactics has rewired what "adequate limits" means for commercial buyers - and the standard $1M CGL primary tower is increasingly the floor of a much taller stack.
In this episode:
00:00 - Cold open: the verdict that changed how one fleet operator thought about limits
02:30 - What "nuclear" actually means: definitions and the trend data
06:00 - The four forces driving the trend: social inflation, litigation funding, reptile theory, anchoring
11:00 - The venues where this is happening (and where it isn't, yet)
15:00 - How umbrella and excess layers are being restructured in 2026
19:00 - What defense strategies are actually moving the needle in trial
22:30 - Buyer playbook: how to think about limits when your peer just took a nine-figure hit
Key takeaways:
- The historical "buy 2x your worst-case" heuristic is broken in casualty-heavy industries.
- Litigation funding is now visible on the plaintiff side in a way that didn't exist five years ago and is structurally changing settlement dynamics.
- Excess capacity is available but pricing and attachment points have moved meaningfully.
Related reading: Westfield Specialty CGL and excess solutions at solutions.westfieldspecialty.com
Brokers reviewing casualty towers can reach Westfield Specialty at solutions.westfieldspecialty.com.
The verdict and claim scenarios discussed in this episode are illustrative and for educational purposes only. They do not constitute legal advice or a representation of coverage under any specific policy.
Loading